Research programme: therapeutic vaccines - ImmunovoAlternative Names: Anti-PD-L1 vaccine - Immunovo; Anti-sclerostin vaccine - Immunovo
Latest Information Update: 24 May 2016
At a glance
- Originator Immunovo
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Bone disorders; Cancer
Most Recent Events
- 06 Apr 2015 Early research in Bone disorders in Netherlands (unspecified route)
- 05 Apr 2015 Early research in Cancer in Netherlands (unspecified route)